Tarsus Q2 net sales climb 69% to USD 173.9 million

Reuters2026/08/06 15:36

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Tarsus posted Q2 net sales of USD 173.9 million, up 69% year over year.
Cash and cash equivalents totaled USD 449.7 million at quarter-end, inclusive of marketable securities.
Lifted 2026 net sales guidance to USD 685-705 million; gross margin seen at about 83%.
Reiterated 2026 SG&A expense guidance of USD 545-565 million; R&D expense outlook reiterated at USD 160-210 million.
Agreed to acquire Alkeus with USD 450 million upfront consideration, split 60% cash and 40% stock; up to USD 350 million in milestones.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tarsus Pharmaceuticals Inc. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Tarsus Q2 net sales climb 69% to USD 173.9 million

You may also like

Crypto prices